imatinib

(redirected from Glivec)
Also found in: Medical.

i·mat·i·nib

 (ĭ-măt′ə-nĭb)
n.
A tyrosine kinase inhibitor, C29H31N7O, used in its mesylate form to treat certain types of leukemia and various other diseases.
References in periodicals archive ?
The dad of one, from Chelmsford, Essex, was treated with the drug Glivec, which was developed thanks to genetics work by Cancer Research UK.
Max had chemotherapy and a relatively new targeted treatment that stemmed from Cancer Research UK's underpinning research called Glivec.
Even though Novartis won the case in court in 2012, they just started enforcing their imatinib patent in 2014, right after the government had regulated, for the second time in the previous 3 years, the price of Glivec, reducing it in about 11%.
Contract award notice: sf a t pea Glivec a Jakavi e dadasa dapates dses p das .
Novartis said on Tuesday that its net income from continuing operations had fallen by $50 million (45 million euros) from April to June this year because it was no longer the only company marketing a special cancer treatment, which it sells under the name Glivec.
Novartis' reorganization of its main drug unit, which accounts for about two-thirds of its $49 billion in annual sales, comes as it struggles with the patent expiration of blood cancer drug Glivec and slower-than-expected revenue from its new heart failure medicine, Entresto.
BEST LEADERSHIP LESSON: Connecting to people's minds can have an impact Swiss pharmaceutical giant Novartis has the lowest attrition rate among multinational drug companies in India, despite its problems over patent protection of its anti-cancer drug Glivec and a proposed reorganisation of some businesses as part of a global plan.
Following the denial of a patent for its leukemia drug, Glivec, (8) Novartis challenged the validity of section 3(d) under TRIPS and the Indian Constitution.
Rod, whose 8-year-old son was diagnosed with CML in 2006, delivered his message during the combined 11th Glivec International Patient Assistance Program (Gipap) and 6th NOA program anniversary celebration.
The US industry had raised the matter of India's rejection of patents for Bristol- Myers Squibb's Sprycel and Novartis AG's Glivec.
According to PCHR's follow-up, the suffering of Leukemia patients, which is a serious cancerous disease that affects blood cells, started in December 2012, as the Glivec 400 mg tab has completely ran out from the Blood Department Pharmacy at Shifa Hospital.
She was given a drug called Glivec which shrank the tumour from nine centimetres to three within a year.